Indication
Contact Dermatitis
5 clinical trials
13 products
1 drug
Clinical trial
Clinical Evaluation of Hydroxyisohexyl 3-cyclohexene Carboxaldehyde (Lyral®) Dose Response StudyStatus: Completed, Estimated PCD: 2013-06-01
Product
Lyral®Clinical trial
Clinical Evaluation of TRUE Test Ethylenediamine Dihydrochloride Allergen: Bioequivalence of Vehicle FormulationsStatus: Completed, Estimated PCD: 2012-08-01
Clinical trial
The Effects of Dupilumab on Allergic Contact DermatitisStatus: Recruiting, Estimated PCD: 2023-12-01
Product
DupilumabClinical trial
An Investigator Initiated Study to Evaluate the Efficacy of Baricitinib In Treatment of Delayed-Type Hypersensitivity Versus Irritant Skin Reactions In Healthy Adult Male SubjectsStatus: Completed, Estimated PCD: 2023-10-16
Product
BaricitinibDrug
VarlilumabClinical trial
Biologics and Blistering - Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation Through Suction BlisteringStatus: Recruiting, Estimated PCD: 2027-01-01
Product
Squaric Acid Dibutyl EsterProduct
AdalimumabProduct
UstekinumabProduct
GuselkumabProduct
CanakinumabProduct
SarilumabProduct
Triamcinolone AcetonideProduct
Betamethasone ValerateProduct
Fluticasone Propionate